Trademark: 86528638
Status Date
Monday, September 24, 2018
Filing Date
Monday, February 9, 2015
Published for Opposition
Tuesday, June 30, 2015
Abandoned Date
Monday, September 24, 2018
5 A combination drug product, namely, a formulation of sirolimus incorporated within a collagen membrane, which, as an implantable drug carrier, enables local delivery of sirolimus to the vascular wall, administered by physicians during surgery
Sep 24, 2018
Abandonment Notice Mailed - No Use Statement Filed
Sep 24, 2018
Abandonment - No Use Statement Filed
Feb 21, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2018
Extension 4 Granted
Feb 19, 2018
Extension 4 Filed
Feb 19, 2018
Teas Extension Received
Aug 19, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2017
Extension 3 Granted
Aug 17, 2017
Extension 3 Filed
Aug 17, 2017
Teas Extension Received
Feb 11, 2017
Notice Of Approval Of Extension Request E-Mailed
Feb 9, 2017
Extension 2 Granted
Feb 9, 2017
Extension 2 Filed
Feb 9, 2017
Teas Extension Received
Sep 20, 2016
Assigned To Examiner
Aug 4, 2016
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2016
Extension 1 Granted
Aug 2, 2016
Extension 1 Filed
Aug 2, 2016
Teas Extension Received
Feb 23, 2016
Noa E-Mailed - Sou Required From Applicant
Jan 12, 2016
Extension Of Time To Oppose Process - Terminated
Dec 22, 2015
Changes/Corrections After Pub Approval Entered
Dec 18, 2015
Assigned To Petition Staff
Dec 9, 2015
Teas Post Publication Amendment Received
Jul 30, 2015
Extension Of Time To Oppose Received
Jun 30, 2015
Official Gazette Publication Confirmation E-Mailed
Jun 30, 2015
Published For Opposition
Jun 10, 2015
Notification Of Notice Of Publication E-Mailed
May 18, 2015
Approved For Pub - Principal Register
May 14, 2015
Assigned To Examiner
Feb 23, 2015
New Application Office Supplied Data Entered In Tram
Feb 12, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
